semaglutide anorexia GLP-1s and eating disorders: What journalists need to know Weight Loss Drugs and Eating

Youll have access to coaching, support groups, and stress management resources

The FDA first approved a GLP-1 agonist specifically for weight loss in November 2021, when semaglutide (Wegovy) received clearance for chronic weight management in adults with obesity or overweight with at least one weight-related condition

It slows down the processes used to digest food and keeps you satisfied longer

Are you ready for a blockbuster discussion about semaglutide (Ozempic/Wegovy), the Hollywood sensation taking the world of obesity management by storm

Fatigue syndrome Some people experience extreme fatigue when starting GLP-1s